.Attributes Medicine, Posted online: 03 September 2024 doi:10.1038/ s41591-024-03223-zThis Perspective calls for inclusion of patients with MASLD as well as dimension of liver end results in cardio-- kidney-- metabolic tests, when data advise mechanistically plausible benefits and scientific security-- and also details points to consider for trial concept as well as regulatory approval.